insights_auto
Kwa nini DUL imepungua kwa 2.24%?
Fahamu zaidichevron_right
DUL:ETR
Alnylam Pharmaceuticals, Inc.
€ 200.90
arrow_downward
-2.24%(-4.60) Siku 1
13 Okt, 17:35:52 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya DUL...
Fungua
€ 202.60
Juu
€ 202.60
Chini
€ 200.90
Mtaji wa soko
29.95B
Wastani wa kiasi cha mauzo
39.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 417.40
Chini kwa wiki 52
€ 177.10
Idadi ya wafanyakazi
elfu 2
Fungua
€ 202.60
Juu
€ 202.60
Chini
€ 200.90
Mtaji wa soko
29.95B
Wastani wa kiasi cha mauzo
39.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 417.40
Chini kwa wiki 52
€ 177.10
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Benzinga
·
saa 3 zilizopita
If You Invested $1000 In Alnylam Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today
Investing.com Canada
·
saa 16 zilizopita
Form 4 Alnylam Pharmaceuticals Inc For: 13 October By Investing.com
Investing.com
·
siku 2 zilizopita
Alnylam EVP Bryan Supran sells $398,855 in shares
Simply Wall Street
·
siku 2 zilizopita
How Securities Fraud Scrutiny Will Impact Alnylam Stock Investors
Wasifu
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Kuhusu Alnylam Pharmaceuticals, Inc.
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 2.5
Lilianzishwa14 Jun 2002
Makao makuu-
Sekta-
Tovutialnylam.com